August 8, 2025 · Form 4 insider transaction
Burnett Patrick sold 3,847 shares of Arcutis Biotherapeutics, Inc. at $14.03 per share, a transaction worth $54.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024 by the Reporting Person, with a plan end date of February 27, 2026.; The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.992 to $14.12, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.